Policy | March 16, 2023
2654 compounds screened for different activities for GPCR profiling: Dr Jitendra Singh
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
Expands robotics to 20+ specialities
Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment
The facility has been set up to manufacture tuberculosis testing cartridges
Patients will no longer need to travel abroad for treatment of acute cardiac diseases
A funding to expand operations and provide better patient care
Proposed combination enhances Pfizer’s position as a leading company in oncology
Kyndryl's multi-cloud management solution leverages AI-based, cloud-hosted models to provide real-time metrics, events, logs, and traces
ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Subscribe To Our Newsletter & Stay Updated
